Skip to main content
Fig. 5 | BMC Pharmacology and Toxicology

Fig. 5

From: Human targeted phenobarbital presents a poor substrate of gut microbiome deciphering new drug targets beyond pharmacokinetic curbs

Fig. 5

Percentage dose recovery (% ± SE, N = 6) from administered dose of phenobarbital determined in various groups: A1 = Control, drug-treated groups based upon post-phenobarbital oral treatment (15 mg/kg of body weight) at sampling times A2 = 2 h, A3 = 3 h, A4 = 4 h, A5 = 5 h and A6 = 6 h. Alphabets on mean bars show a significant difference between groups (P ≤ 0.05)

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us